ANGO vs LIN
AngioDynamics Inc (ANGO) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
ANGO currently screens at market cap $378.5M. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the ANGO and LIN stock pages for the full models.
Not investment advice.